Anebulo Pharmaceuticals, Inc. (ANEB)
NASDAQ: ANEB · Real-Time Price · USD
1.470
-0.360 (-19.67%)
At close: Nov 7, 2024, 4:00 PM
1.540
+0.070 (4.75%)
After-hours: Nov 7, 2024, 5:08 PM EST
Anebulo Pharmaceuticals Market Cap
Anebulo Pharmaceuticals has a market cap or net worth of $38.12 million as of November 7, 2024. Its market cap has decreased by -50.59% in one year.
Market Cap
38.12M
Enterprise Value
45.40M
1-Year Change
-50.59%
Ranking
Category
Stock Price
$1.47
Market Cap Chart
Since the IPO on May 7, 2021, Anebulo Pharmaceuticals's market cap has decreased from $162.86M to $38.12M, a decrease of -76.59%. That is a compound annual growth rate of -33.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2024 | 38.12M | -38.54% |
| Dec 29, 2023 | 62.03M | -0.15% |
| Dec 30, 2022 | 62.13M | -56.73% |
| Dec 29, 2021 | 143.57M | -11.85% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Affimed | 51.28M |
| CEL-SCI | 51.04M |
| Lucid Diagnostics | 50.63M |
| SCYNEXIS | 49.97M |
| Elicio Therapeutics | 49.60M |
| OncoCyte | 48.82M |
| Aadi Bioscience | 48.25M |
| Fortress Biotech | 47.68M |